C2974540_interactsWith_C0036193 | Knowledge4COVID-19

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C0020461> <https://research.tib.eu/covid-19/entity/C0020649> <https://research.tib.eu/covid-19/entity/C1371678>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	increase
?:interaction	The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Saralasin.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0036193>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB06763>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C2974540>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB08907>
is ?:subClassOf of	<https://research.tib.eu/covid-19/entity/C2974540_hasPharmacodynamic_C0036193>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C2974540_interactsWith_C0036193>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C2974540_interactsWith_C0036193>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all